CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.

doi:10.1186/ar3444

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.

Arthritis research & therapy - 16 Aug 2011

Rodríguez-Rodríguez Luis, González-Juanatey Carlos, García-Bermúdez Mercedes, Vázquez-Rodríguez Tomas R, Miranda-Filloy Jose A, Fernández-Gutiérrez Benjamin, Llorca Javier, Martin Javier, González-Gay Miguel A

Abstract excerpt

INTRODUCTION: The aim of our study was to analyze the influence of the CCR5Δ32 polymorphism in the risk of cardiovascular (CV) events and subclinical atherosclerosis among patients with rheumatoid arthritis (RA). METHODS: A total of 645 patients fulfilling the American Rheumatism Association 1987 revised classification criteria for RA were studied. Patients were genotyped for the CCR5 rs333 polymorphism using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Carotid Intima-Media Thickness

Share to Cohort Studies

Share to Heterozygote

Share to Proportional Hazards Models

Share to Receptors, CCR5

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 21846359
DOI: 10.1186/ar3444
PMCID: PMC3239375

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.PMID 21846359Read ↗

The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study.Semantic proximity Read ↗

Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.Semantic proximity Read ↗

Association of the CCR5Δ32 polymorphism and its ligand RANTES-403G/A polymorphism with coronary artery disease: a meta-analysis.Semantic proximity Read ↗

The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.Semantic proximity Read ↗

Genetic markers of cardiovascular disease in rheumatoid arthritis.Semantic proximity Read ↗

Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.Semantic proximity Read ↗

TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.Semantic proximity Read ↗

Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.Semantic proximity Read ↗

Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.Semantic proximity Read ↗

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markersSemantic proximity Read ↗

The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.Semantic proximity Read ↗

CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.